CLINICAL STUDY: OBESITY, DIABETES, AND HEART DISEASE
The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men
Eunyoung Cho, ScD*,*,
Eric B. Rimm, ScD*  ,
Meir J. Stampfer, MD, DrPH*,
Walter C. Willett, MD, DrPH* and
Frank B. Hu, MD, PhD
* Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women’s Hospital, Boston, Massachusetts, USA
Department of Nutrition, Boston, Massachusetts, USA
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
Manuscript received December 4, 2001;
revised manuscript received May 7, 2002,
accepted May 24, 2002.
* Reprint requests and correspondence: Dr. Eunyoung Cho, Channing Laboratory, 181 Longwood Avenue, Boston, Massachusetts 02115, USA
Eunyoung.Cho{at}channing.harvard.edu
OBJECTIVES: The goal of this study was to examine the impact of diabetes and prior myocardial infarction (MI) on mortality in men.
BACKGROUND: Previous studies have suggested that a history of diabetes and a prior MI confer similar risk for subsequent fatal coronary heart disease (CHD). Few studies have examined duration of diabetes in relation to mortality.
METHODS: We examined type 2 diabetes and prior MI in relation to mortality among 51,316 men aged 40 to 75 years in the Health Professionals Follow-up Study.
RESULTS: During 10 years of follow-up, we documented 4,150 deaths from all causes, including 1,124 deaths from CHD. Compared with men without diabetes or prior MI at baseline, the multivariate relative risks (RRs) for fatal CHD were 3.84 (95% confidence interval [CI], 3.12 to 4.71) for those with diabetes only, 7.88 (95% CI, 6.86 to 9.05) for those with MI only, and 13.41 (95% CI, 10.49 to 17.16) for those with both diabetes and MI. The corresponding RRs for total mortality were 1.91 (95% CI, 1.70 to 2.15), 2.23 (95% CI, 2.03 to 2.45), and 3.13 (95% CI, 2.56 to 3.84), respectively. Duration of diabetes was an independent risk factor for total as well as CHD mortality; the multivariate RRs of CHD mortality for increasing duration of diabetes ( 5 years, 6 to 10 years, 11 to 15 years, 16 to 25 years, 26+ years) were 1.63, 1.93, 2.35, 2.31, and 3.87, respectively (p for trend <0.001), compared with nondiabetic participants.
CONCLUSIONS: These findings support that both diabetes and MI are associated with elevated total and CHD mortality, and having both conditions is particularly hazardous. Longer duration of diabetes is a strong predictor of death among diabetic men.
|
Abbreviations and Acronyms
| | CHD | | coronary heart disease | | CI | | confidence interval | | CVD | | cardiovascular disease | | HPFS | | Health Professionals Follow-up Study | | MI | | myocardial infarction |
|
This article has been cited by other articles:
|
|
|
|
 
H. M. Lee, S. J. Chung, V. A. Lopez, and N. D. Wong
Association of FVC and Total Mortality in US Adults With Metabolic Syndrome and Diabetes
Chest,
July 1, 2009;
136(1):
171 - 176.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Dale, K. Midthjell, T. I. Nilsen, R. Wiseth, and L. J. Vatten
Glycaemic control in newly diagnosed diabetes patients and mortality from ischaemic heart disease: 20-year follow-up of the HUNT Study in Norway
Eur. Heart J.,
June 1, 2009;
30(11):
1372 - 1377.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Verhaert and J. D. Thomas
Dysglycemia and acute myocardial infarction the role of echocardiography.
J. Am. Coll. Cardiol. Img.,
May 1, 2009;
2(5):
600 - 603.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. W. Worm, S. De Wit, R. Weber, C. A. Sabin, P. Reiss, W. El-Sadr, A. D. Monforte, O. Kirk, E. Fontas, F. Dabis, et al.
Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)
Circulation,
February 17, 2009;
119(6):
805 - 811.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Akbari, S. Akbari, and L. R. Pasquale
The Association of Primary Open-angle Glaucoma With Mortality: A Meta-analysis of Observational Studies
Arch Ophthalmol,
February 1, 2009;
127(2):
204 - 210.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. R. Dagenais MD, A. St-Pierre PhD, P. Gilbert MD, B. Lamarche PhD, J.-P. Despres PhD, P.-M. Bernard MSc, and P. Bogaty MD
Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease
Can. Med. Assoc. J.,
January 6, 2009;
180(1):
40 - 47.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Dale, L. J Vatten, T. I. Nilsen, K. Midthjell, and R. Wiseth
Secular decline in mortality from coronary heart disease in adults with diabetes mellitus: cohort study
BMJ,
August 13, 2008;
337(jul01_2):
a236 - a236.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Wassink, Y. Van Der Graaf, S. S Soedamah-Muthu, W. Spiering, and F. L. Visseren
Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease
Diabetes and Vascular Disease Research,
June 1, 2008;
5(2):
114 - 122.
[Abstract]
[PDF]
|
|
|
|
|
|
|
A. C. Dale, T. I. Nilsen, L. Vatten, K. Midthjell, and R. Wiseth
Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74 914 individuals in the HUNT 1 Study
Eur. Heart J.,
December 1, 2007;
28(23):
2924 - 2929.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. C. Simon, H. Chen, M. Schwarzschild, and A. Ascherio
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Neurology,
October 23, 2007;
69(17):
1688 - 1695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Siyambalapitiya, U. Bulugahapitiya, J. Sithole, S. Song, D. J.S. Fernando, and I. Idris
Combining Population Health and Baseline Risk Strategy by Determining an Age Cutoff for Initiating Statins in Patients With Diabetes: A population-based study
Diabetes Care,
August 1, 2007;
30(8):
2025 - 2029.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Hsueh, E. D. Abel, J. L. Breslow, N. Maeda, R. C. Davis, E. A. Fisher, H. Dansky, D. A. McClain, R. McIndoe, M. K. Wassef, et al.
Recipes for Creating Animal Models of Diabetic Cardiovascular Disease
Circ. Res.,
May 25, 2007;
100(10):
1415 - 1427.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. W. Gowdak, F. J. de Paula, L. A. M. Cesar, E. E. M. Filho, L. E. Ianhez, E. M. Krieger, J. A. F. Ramires, and J. J. G. De Lima
Diabetes and coronary artery disease impose similar cardiovascular morbidity and mortality on renal transplant candidates
Nephrol. Dial. Transplant.,
May 1, 2007;
22(5):
1456 - 1461.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Erdmann, J. A. Dormandy, B. Charbonnel, M. Massi-Benedetti, I. K. Moules, A. M. Skene, and on behalf of the PROactive Investigators
The Effect of Pioglitazone on Recurrent Myocardial Infarction in 2,445 Patients With Type 2 Diabetes and Previous Myocardial Infarction: Results From the PROactive (PROactive 05) Study
J. Am. Coll. Cardiol.,
May 1, 2007;
49(17):
1772 - 1780.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Yang, N. Sambandam, X. Han, R. W. Gross, M. Courtois, A. Kovacs, M. Febbraio, B. N. Finck, and D. P. Kelly
CD36 Deficiency Rescues Lipotoxic Cardiomyopathy
Circ. Res.,
April 27, 2007;
100(8):
1208 - 1217.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. V. G. Katakam, J. E. Jordan, J. A. Snipes, C. D. Tulbert, A. W. Miller, and D. W. Busija
Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance
Am J Physiol Regulatory Integrative Comp Physiol,
February 1, 2007;
292(2):
R920 - R926.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Buse, H. N. Ginsberg, G. L. Bakris, N. G. Clark, F. Costa, R. Eckel, V. Fonseca, H. C. Gerstein, S. Grundy, R. W. Nesto, et al.
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association
Circulation,
January 2, 2007;
115(1):
114 - 126.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Buse, H. N. Ginsberg, G. L. Bakris, N. G. Clark, F. Costa, R. Eckel, V. Fonseca, H. C. Gerstein, S. Grundy, R. W. Nesto, et al.
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A scientific statement from the American Heart Association and the American Diabetes Association
Diabetes Care,
January 1, 2007;
30(1):
162 - 172.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Bax, R. O. Bonow, D. Tschope, S. E. Inzucchi, E. Barrett, and on behalf of the Global Dialogue Group for the Eva
The Potential of Myocardial Perfusion Scintigraphy for Risk Stratification of Asymptomatic Patients With Type 2 Diabetes
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
754 - 760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Joyeux-Faure, E. Rossini, C. Ribuot, and P. Faure
Fructose-fed rat hearts are protected against ischemia-reperfusion injury.
Experimental Biology and Medicine,
April 1, 2006;
231(4):
456 - 462.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Grundy
Diabetes and Coronary Risk Equivalency: What does it mean?
Diabetes Care,
February 1, 2006;
29(2):
457 - 460.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Juutilainen, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso
Type 2 Diabetes as a "Coronary Heart Disease Equivalent": An 18-year prospective population-based study in Finnish subjects
Diabetes Care,
December 1, 2005;
28(12):
2901 - 2907.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Valensi, J. Paries, V. Brulport-Cerisier, F. Torremocha, R.-N. Sachs, G. Vanzetto, E. Cosson, B. Lormeau, J.-R. Attali, R. Marechaud, et al.
Predictive Value of Silent Myocardial Ischemia for Cardiac Events in Diabetic Patients: Influence of age in a French multicenter study
Diabetes Care,
November 1, 2005;
28(11):
2722 - 2727.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Elhendy, A. Huurman, A. F.L. Schinkel, J. J. Bax, R. T. van Domburg, R. Valkema, E. Biagini, and D. Poldermans
Association of Ischemia on Stress99mTc-Tetrofosmin Myocardial Perfusion Imaging with All-Cause Mortality in Patients with Diabetes Mellitus
J. Nucl. Med.,
October 1, 2005;
46(10):
1589 - 1595.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Mantzoros, T. Li, J. E. Manson, J. B. Meigs, and F. B. Hu
Circulating Adiponectin Levels Are Associated with Better Glycemic Control, More Favorable Lipid Profile, and Reduced Inflammation in Women with Type 2 Diabetes
J. Clin. Endocrinol. Metab.,
August 1, 2005;
90(8):
4542 - 4548.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cusick, A. D. Meleth, E. Agron, M. R. Fisher, G. F. Reed, G. L. Knatterud, F. B. Barton, M. D. Davis, F. L. Ferris III, E. Y. Chew, et al.
Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study report no. 27
Diabetes Care,
March 1, 2005;
28(3):
617 - 625.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F Boccara and A Cohen
Interplay of diabetes and coronary heart disease on cardiovascular mortality
Heart,
December 1, 2004;
90(12):
1371 - 1373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S G Wannamethee, A G Shaper, and L Lennon
Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease
Heart,
December 1, 2004;
90(12):
1398 - 1403.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. S. Lim, R. J. MacFadyen, and G. Y. H. Lip
Diabetes Mellitus, the Renin-Angiotensin-Aldosterone System, and the Heart
Arch Intern Med,
September 13, 2004;
164(16):
1737 - 1748.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Malik, N. D. Wong, S. S. Franklin, T. V. Kamath, G. J. L'Italien, J. R. Pio, and G. R. Williams
Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults
Circulation,
September 7, 2004;
110(10):
1245 - 1250.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Schulze, E. B. Rimm, I. Shai, N. Rifai, and F. B. Hu
Relationship Between Adiponectin and Glycemic Control, Blood Lipids, and Inflammatory Markers in Men With Type 2 Diabetes
Diabetes Care,
July 1, 2004;
27(7):
1680 - 1687.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Schulze, E. B. Rimm, T. Li, N. Rifai, M. J. Stampfer, and F. B. Hu
C-Reactive Protein and Incident Cardiovascular Events Among Men With Diabetes
Diabetes Care,
April 1, 2004;
27(4):
889 - 894.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Winer and J. R. Sowers
Epidemiology of Diabetes
J. Clin. Pharmacol.,
April 1, 2004;
44(4):
397 - 405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Fox, L. Sullivan, R. B. D'Agostino Sr, and P. W.F. Wilson
The Significant Effect of Diabetes Duration on Coronary Heart Disease Mortality: The Framingham Heart Study
Diabetes Care,
March 1, 2004;
27(3):
704 - 708.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. D. Lee, A. R. Folsom, J. S. Pankow, F. L. Brancati, and For the Atherosclerosis Risk in Communities (ARIC)
Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial Infarction
Circulation,
February 24, 2004;
109(7):
855 - 860.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Jordan, S. A. Simandle, C. D. Tulbert, D. W. Busija, and A. W. Miller
Fructose-Fed Rats Are Protected against Ischemia/Reperfusion Injury
J. Pharmacol. Exp. Ther.,
December 1, 2003;
307(3):
1007 - 1011.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Ma, J. Cutter, C. E. Tan, S. K. Chew, and E. S. Tai
Associations of Diabetes Mellitus and Ethnicity with Mortality in a Multiethnic Asian Population: Data from the 1992 Singapore National Health Survey
Am. J. Epidemiol.,
September 15, 2003;
158(6):
543 - 552.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Hu, D. Zhang, L. Swenson, G. Chakrabarti, E. D. Abel, and S. E. Litwin
Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload
Am J Physiol Heart Circ Physiol,
August 7, 2003;
285(3):
H1261 - H1269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K.-H. Mak and S. M Haffner
Diabetes abolishes the gender gap in coronary heart disease
Eur. Heart J.,
August 1, 2003;
24(15):
1385 - 1386.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. B. Hu and J. E. Manson
Walking: The Best Medicine for Diabetes?
Arch Intern Med,
June 23, 2003;
163(12):
1397 - 1398.
[Full Text]
[PDF]
|
|
|
|
